WO2024062311 - THERAPEUTIC SUBSTANCE MONITORING
National phase entry is expected:
Publication Number
WO/2024/062311
Publication Date
28.03.2024
International Application No.
PCT/IB2023/058684
International Filing Date
01.09.2023
Title **
[English]
THERAPEUTIC SUBSTANCE MONITORING
[French]
SURVEILLANCE D'UNE SUBSTANCE THÉRAPEUTIQUE
Applicants **
COCHLEAR LIMITED
Inventors
SMYTH, Daniel
DUECK, Wolfram Frederik
Priority Data
63/408,182
20.09.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2861 | |
| EPO | Filing, Examination, Granting | 23282 | |
| Japan | Filing, Examination, Granting | 2842 | |
| South Korea | Filing, Examination, Granting | 2563 | |
| USA | Filing, Examination, Granting | 8740 |
Total:
40,288
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Presented herein are techniques for monitoring a state, amount, and/or concentration of a therapeutic substance in, for example, an implantable component of an implantable medical device. In particular, an implantable component can include at least one therapeutic substance portion having a therapeutic substance therein for delivery to a recipient. The techniques presented herein measure the impedance across the at least one therapeutic substance portion and use the measured impedance to estimate the state, amount and/or concentration of the therapeutic substance within the at least one therapeutic substance portion.[French]
L'invention concerne des techniques de surveillance d'un état, d'une quantité et/ou d'une concentration d'une substance thérapeutique dans, par exemple, un composant implantable d'un dispositif médical implantable. En particulier, un composant implantable peut comprendre au moins une partie à substance thérapeutique, à l'intérieur de laquelle se trouve une substance thérapeutique destinée à être administrée à un receveur. Les techniques présentées ici mesurent l'impédance à travers ladite au moins une partie à substance thérapeutique et utilisent l'impédance mesurée pour estimer l'état, la quantité et/ou la concentration de la substance thérapeutique à l'intérieur de ladite au moins une partie à substance thérapeutique.